Designing proof of concept studies to establish intellectual property for opportunity to develop a new therapeutic modality that provides a replacement for antibody treatments and injectable therapeutics via oral and topical delivery. Additional potential applications as an injectable nanoparticle carrier platform for delivery of chemotherapies and biologics to treat a variety of diseases.